id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2003-N-0042-0004,FDA,FDA-2003-N-0042,Supporting Statement - Environmental Impact Considerations - 21 CFR Part 25,Supporting & Related Material,Background Material,2003-12-08T05:00:00Z,2003,12,,,2025-02-25T18:18:35Z,,0,0,0900006480481756
FDA-2003-N-0042-0003,FDA,FDA-2003-N-0042,Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Environmental Impact Considerations,Notice,Notice of Approval,2003-12-08T05:00:00Z,2003,12,,,2025-02-25T18:00:54Z,03-29068,0,0,0900006480481755
FDA-2003-N-0042-0005,FDA,FDA-2003-N-0042,Supporting Statement - Environmental Impact Considerations - 21 CFR Part 25,Supporting & Related Material,Background Material,2003-12-08T05:00:00Z,2003,12,,,2025-02-25T18:26:20Z,,0,0,0900006480481757
FDA-2003-N-0042-0002,FDA,FDA-2003-N-0042,Agency Information Collection Activities; Submission for OMB Review; Comment Request; Environmental Impact Considerations,Notice,30 Day Proposed Information Collection,2003-07-01T04:00:00Z,2003,7,2003-06-26T04:00:00Z,2003-07-29T03:59:59Z,2025-02-25T17:56:40Z,03-16107,0,0,0900006480481754
FDA-2003-N-0042-0001,FDA,FDA-2003-N-0042,Agency Information Collection Activities; Proposed Collection; Comment Request; Environmental Impact Considerations,Notice,60 Day Proposed Information Collection,2003-03-18T05:00:00Z,2003,3,2003-03-17T05:00:00Z,2003-05-17T03:59:59Z,2025-02-25T17:49:42Z,03-6228,0,0,0900006480481751